Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-12
2011-07-12
Olson, Eric S (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S257000, C514S653000, C514S513000, C514S263340, C549S406000, C544S245000, C544S273000, C564S365000, C560S183000
Reexamination Certificate
active
07977378
ABSTRACT:
Compositions and methods are provided for the treatment of obesity in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of a weight loss enhancing beta-3-adrenergic compound of Cycle I, and a different weight loss enhancing adenylate cyclase receptor replenishing compound of Cycle II, in conjunction with a pharmaceutically acceptable diluent or carrier, wherein the Compound of Cycle I and the compound of Cycle II are administered sequentially. The composition may be present as a kit having each sequence in blister packs.
REFERENCES:
patent: 5716976 (1998-02-01), Bernstein
patent: 2006/0229274 (2006-10-01), Hsue
patent: 2009/0054372 (2009-02-01), Goldsmith
Richard B. Silverman, “The Organic Chemistry of Drug Design and Drug Action” published 1992 by Academic Press, chapter 2, pp. 4-47.
“STN Database Descriptions” 2006 Chemical Abstracts catalog, published 2006 by Chemical Abstracts Service, p. 52.
Lord Nancy
Nancy Lord, Ltd.
Olson Eric S
LandOfFree
Compositions and methods for enhancing weight-loss by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for enhancing weight-loss by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for enhancing weight-loss by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2626621